|
2024
|
Invention
|
Compounds, compositions, and methods for modulating cftr.
The present disclosure is directed to ... |
|
2023
|
Invention
|
Methods of treating pulmonary diseases and disorders.
The present disclosure features disclosed ... |
|
2020
|
Invention
|
Proteasome activity enhancing compounds. The present invention is directed to compounds that inhi... |
|
|
Invention
|
Proteasome activity enhancing compounds. The present invention is directed to compounds having th... |
|
|
Invention
|
Compounds, compositions, and methods for modulating cftr. The present disclosure is directed to d... |
|
2019
|
Invention
|
Compounds, compositions, and methods of increasing cftr activity. The present disclosure features... |
|
|
Invention
|
Compounds, compositions, and methods for increasing cftr activity. The present disclosure is dire... |
|
|
Invention
|
Proteasome activity enhancing compounds. The present invention is directed towards compounds havi... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of disorders in the nature of digestive disorders, ... |
|
2018
|
Invention
|
Methods of quantifying cftr protein expression.
The present disclosure is directed in part to me... |
|
|
Invention
|
Methods of quantifying cftr protein expression. e.g.e.g., by an Enzyme-Linked Immunosorbent Assay... |
|
|
Invention
|
Compounds, compositions, and methods for increasing cftr activity. The present disclosure feature... |
|
|
Invention
|
Compounds, compositions, and methods for increasing cftr activity.
The present disclosure featur... |
|
|
Invention
|
Compounds, compositions and methods for increasing cftr activity. The present disclosure features... |
|
|
Invention
|
4-sulfonylaminocarbonylquinoline derivatives for increasing cftr activity.
The present disclosur... |
|
|
Invention
|
4-sulfonylaminocarbonylquinoline derivatives for increasing cftr activity. The present disclosure... |
|
2017
|
Invention
|
Proteasome activity enhancing compounds.
The present invention is directed to compounds having t... |
|
|
Invention
|
N-phenyl-2-(3-phenyl-6-oxo-1,6-dihydropyridazin-1-yl)acetamide derivatives for treating cystic fi... |
|
|
Invention
|
Compounds, compositions, and methods for increasing cftr activity.
The present disclosure is dir... |
|
|
Invention
|
Compounds, compositions, and methods for modulating cftr. The present disclosure is directed to p... |
|
|
Invention
|
Pyridazine derivatives, compositions and methods for modulating cftr. The present disclosure is d... |
|
|
Invention
|
Compounds, compositions, and methods for increasing cftr activity. The disclosure encompasses com... |
|
|
Invention
|
Methods of identifying cftr modulators.
The present disclosure is directed to methods of identif... |
|
|
Invention
|
Methods of identifying cftr modulators. The present disclosure is directed to methods of identify... |
|
|
Invention
|
Silicone atoms containing ivacaftor analogues. The present disclosure is directed to disclosed co... |
|
|
Invention
|
Proteostasis regulators. The present invention is directed to compounds having the Formulae (Ia-I... |
|
2016
|
Invention
|
Methods of treating pulmonary diseases and disorders. The present disclosure features disclosed m... |
|
|
Invention
|
Isoxazole derivatives for use in the treatment of pulmonary diseases and disorders. The present d... |
|
|
Invention
|
Compounds, compositions and methods of increasing cftr activity. The present disclosure features ... |
|
2015
|
Invention
|
Derivatives of 5-(hetero)arylpyrazol-3-carboxylic amide or 1-(hetero)aryltriazol-4-carboxylic ami... |
|
|
Invention
|
Derivatives of 5-phenyl- or 5-heteroarylathiazol-2-carboxylic amide useful for the treatment of i... |
|
|
Invention
|
Derivatives of 3-heteroarylisoxazol-5-carboxylic amide useful for the treatment of inter alia cys... |
|
|
G/S
|
Chemicals for scientific research purposes for synthesizing small molecule compounds; proteostasi... |
